HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy

NCT05322720 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL: EOC202
DRUG: albumin-bound paclitaxel

Sponsor

Taizhou EOC Pharma Co., Ltd.